Features of functional and dysfunctional CD8+ T cells to guide HIV vaccine development

被引:3
作者
Bhattacharyya, Shaown [1 ]
Crain, Charles R. [1 ]
Goldberg, Benjamin [1 ]
Gaiha, Gaurav D. [1 ,2 ,3 ]
机构
[1] Ragon Inst Mass Gen MIT & Harvard, Cambridge, MA 02139 USA
[2] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02115 USA
[3] Ragon Inst Mass Gen Harvard & MIT, 400 Technol Sq, Room 862, Cambridge, MA 02139 USA
基金
美国国家卫生研究院;
关键词
CD8(+) T cells; epitope specificity; human immunodeficiency virus; T cell dysfunction; vaccines; PD-1; EXPRESSION; NATURAL CONTROL; DOUBLE-BLIND; EXHAUSTION; RESPONSES; EPITOPES; INFECTION; PROLIFERATION; DETERMINANTS; REPLICATION;
D O I
10.1097/COH.0000000000000812
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of reviewCD8(+) T cell responses are a key component of the host immune response to human immunodeficiency virus (HIV) but vary significantly across individuals with distinct clinical outcomes. These differences help inform the qualitative features of HIV-specific CD8(+) T cells that we should aim to induce by vaccination.Recent findingsWe review previous and more recent findings on the features of dysfunctional and functional CD8(+) T cell responses that develop in individuals with uncontrolled and controlled HIV infection, with particular emphasis on proliferation, cytotoxic effector function, epitope specificity, and responses in lymph nodes. We also discuss the implications of these findings for both prophylactic and therapeutic T cell vaccine development within the context of T cell vaccine trials.The induction of HIV specific CD8(+) T cell responses is an important goal of ongoing vaccine efforts. Emerging data on the key features of CD8(+) T cell responses that distinguish individuals who spontaneously control from those with progressive disease continues to provide key guidance.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 92 条
  • [1] Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation
    Abdel-Hakeem, Mohamed S.
    Manne, Sasikanth
    Beltra, Jean-Christophe
    Stelekati, Erietta
    Chen, Zeyu
    Nzingha, Kito
    Ali, Mohammed-Alkhatim
    Johnson, John L.
    Giles, Josephine R.
    Mathew, Divij
    Greenplate, Allison R.
    Vahedi, Golnaz
    Wherry, E. John
    [J]. NATURE IMMUNOLOGY, 2021, 22 (08) : 1008 - +
  • [2] Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial Dysfunction
    Alrubayyi, Aljawharah
    Moreno-Cubero, Elia
    Hameiri-Bowen, Dan
    Matthews, Rebecca
    Rowland-Jones, Sarah
    Schurich, Anna
    Peppa, Dimitra
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection
    Angin, Mathieu
    Volant, Stevenn
    Passaes, Caroline
    Lecuroux, Camille
    Monceaux, Valerie
    Dillies, Marie-Agnes
    Valle-Casuso, Jose Carlos
    Pancino, Gianfranco
    Vaslin, Bruno
    Le Grand, Roger
    Weiss, Laurence
    Goujard, Cecile
    Meyer, Laurence
    Boufassa, Faroudy
    Muller-Trutwin, Michaela
    Lambotte, Olivier
    Saez-Cirion, Asier
    [J]. NATURE METABOLISM, 2019, 1 (07) : 704 - 716
  • [4] T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
    Arunachalam, Prabhu S.
    Charles, Tysheena P.
    Joag, Vineet
    Bollimpelli, Venkata S.
    Scott, Madeleine K. D.
    Wimmers, Florian
    Burton, Samantha L.
    Labranche, Celia C.
    Petitdemange, Caroline
    Gangadhara, Sailaja
    Styles, Tiffany M.
    Quarnstrom, Clare F.
    Walter, Korey A.
    Ketas, Thomas J.
    Legere, Traci
    Reddy, Pradeep Babu Jagadeesh
    Kasturi, Sudhir Pai
    Tsai, Anthony
    Yeung, Bertrand Z.
    Gupta, Shakti
    Tomai, Mark
    Vasilakos, John
    Shaw, George M.
    Kang, Chil-Yong
    Moore, John P.
    Subramaniam, Shankar
    Khatri, Purvesh
    Montefiori, David
    Kozlowski, Pamela A.
    Derdeyn, Cynthia A.
    Hunter, Eric
    Masopust, David
    Amara, Rama R.
    Pulendran, Bali
    [J]. NATURE MEDICINE, 2020, 26 (06) : 932 - +
  • [5] Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
    Bailon, Lucia
    Llano, Anuska
    Cedeno, Samandhy
    Escriba, Tuixent
    Rosas-Umbert, Miriam
    Parera, Mariona
    Casadella, Maria
    Lopez, Miriam
    Perez, Francisco
    Oriol-Tordera, Bruna
    Ruiz-Riol, Marta
    Coll, Josep
    Perez, Felix
    Leselbaum, Anne R.
    McGowan, Ian
    Sengupta, Devi
    Wee, Edmund G.
    Hanke, Tomas
    Paredes, Roger
    Alarcon-Soto, Yovaninna
    Clotet, Bonaventura
    Noguera-Julian, Marc
    Brander, Christian
    Molto, Jose
    Mothe, Beatriz
    Rivero, Angel
    [J]. NATURE MEDICINE, 2022, 28 (12) : 2611 - +
  • [6] HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
    Betts, Michael R.
    Nason, Martha C.
    West, Sadie M.
    De Rosa, Stephen C.
    Migueles, Stephen A.
    Abraham, Jonathan
    Lederman, Michael M.
    Benito, Jose M.
    Goepfert, Paul A.
    Connors, Mark
    Roederer, Mario
    Koup, Richard A.
    [J]. BLOOD, 2006, 107 (12) : 4781 - 4789
  • [7] Multiple Origins of Virus Persistence during Natural Control of HIV Infection
    Boritz, Eli A.
    Darko, Samuel
    Swaszek, Luke
    Wolf, Gideon
    Wells, David
    Wu, Xiaolin
    Henry, Amy R.
    Laboune, Farida
    Hu, Jianfei
    Ambrozak, David
    Hughes, Marybeth S.
    Hoh, Rebecca
    Casazza, Joseph P.
    Vostal, Alexander
    Bunis, Daniel
    Nganou-Makamdop, Krystelle
    Lee, James S.
    Migueles, Stephen A.
    Koup, Richard A.
    Connors, Mark
    Moir, Susan
    Schacker, Timothy
    Maldarelli, Frank
    Hughes, Stephen H.
    Deeks, Steven G.
    Douek, Daniel C.
    [J]. CELL, 2016, 166 (04) : 1004 - 1015
  • [8] The B-Cell Follicle in HIV Infection: Barrier to a Cure
    Bronnimann, Matthew P.
    Skinner, Pamela J.
    Connick, Elizabeth
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [9] Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
    Buchbinder, Susan P.
    Mehrotra, Devon V.
    Duerr, Ann
    Fitzgerald, Daniel W.
    Mogg, Robin
    Li, David
    Gilbert, Peter B.
    Lama, Javier R.
    Marmor, Michael
    del Rio, Carlos
    McElrath, M. Juliana
    Casimiro, Danilo R.
    Gottesdiener, Keith M.
    Chodakewitz, Jeffrey A.
    Corey, Lawrence
    Robertson, Michael N.
    [J]. LANCET, 2008, 372 (9653) : 1881 - 1893
  • [10] Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway
    Buckley, AF
    Kuo, CT
    Leiden, JM
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 698 - 704